In addition, it is important to note that amino acid mutations of Keap1 were found to highly expressed in the human lung, breast and other somatic cancers, and these mutants were also identified leading to the deteriorative activation of Nrf2 [2,3,4,5,6]. Here, KEAP1 is linked to cancer.